US-based VBI Vaccines sells manufacturing capabilities to China's Brii Biosciences for $33 M

US-based VBI Vaccines Inc., a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and t...

February 16, 2024 | Friday | News
China develops potential new treatment for brain tumours and Parkinson’s disease

A joint multi-disciplinary team from The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine...

February 15, 2024 | Thursday | News
Hong Kong-based genomics company Prenetics initiates new project to focus on accelerated ageing in space

Prenetics Global Limited, a leading genomics-driven health sciences company, has announced the signing of a Memorandum o...

February 12, 2024 | Monday | News
Chugai’s Paroxysmal nocturnal hemoglobinuria drug bags world’s first approval in China

Japan's Chugai Pharmaceutical has announced that crovalimab, a humanised complement inhibitor C5 monoclonal antibody, ha...

February 13, 2024 | Tuesday | News
Yiviva allies AstraZeneca to develop platforms, tools, and botanical therapeutics in China

Yiviva, a clinical-stage, platform biotechnology company developing systems biology medicines to treat aging-related dis...

February 8, 2024 | Thursday | News
I-Mab divests China business to become US-based biotech firm

I-Mab, a global biotech company exclusively focused on bringing highly differentiated immunotherapies and biologics for ...

February 9, 2024 | Friday | News
China's Luye Pharma partners with Korea-based Myung In Pharm to improve Alzheimer's related dementia treatment

China-based Luye Pharma Group has entered into an agreement with South Korea's Myung In Pharm, granting the latter the e...

February 7, 2024 | Wednesday | News
Singapore, China explore use of spider-silk inspired electrode to shape future of medical devices

An international team of scientists from Singapore's Nanyang Technological University, Chinese Academy of Sciences, Nanj...

February 2, 2024 | Friday | News
MGI unveils expansion of automation product lines for life science and healthcare research

MGI Tech Co., a China-based provider of cutting-edge tools and technology for life science and healthcare research, has ...

January 31, 2024 | Wednesday | News
Study in Hong Kong sparks new therapeutic target for lung cancer

Lung cancer is the leading cause of cancer deaths in Hong Kong and worldwide, but there is still an unmet clinical need ...

January 30, 2024 | Tuesday | News
Glenmark inks licensing agreement with Chinese firms for oncology drug Envafolimab

Glenmark Specialty S.A. (GSSA), a subsidiary of India-based Glenmark Pharmaceuticals Ltd. (Glenmark), has announced the ...

January 25, 2024 | Thursday | News
WuXi XDC and Celltrion sign MoU for integrated services for Antibody-Drug Conjugates

WuXi XDC, China-based contract research, development and manufacturing organisation (CRDMO) focused on antibody drug con...

January 24, 2024 | Wednesday | News
Sanyou Biopharma launches Super Trillion Peptide Molecule Discovery Platform

China-based startup Sanyou Biopharmaceuticals has officially announced the launch of its "Sanyou Super Trillion Pep...

January 22, 2024 | Monday | News
Hong Kong backs establishment of first Assistive Technology Rehabilitation and Education Centre in Mongolia

The Department of Rehabilitation Sciences of The Hong Kong Polytechnic University (PolyU) and the Department of Physical...

January 19, 2024 | Friday | News
Chinese medicine drug for myofibrillar myopathy receives orphan drug designation by US FDA

The Centre for Chinese Herbal Medicine Drug Development of Hong Kong Baptist University (HKBU) has develo...

January 12, 2024 | Friday | News
China's WuXi Biologics announces research service agreement worth $20 M with BioNTech

China's WuXi Biologics has signed a research service agreement with Germany-based BioNTech SE, a next generation immunot...

January 11, 2024 | Thursday | News
Novartis acquires China-based startup SanReno Therapeutics to enhance kidney diseases treatment

China-based startup SanReno Therapeutics,  a clinical-stage company specializing in the discovery, development...

January 5, 2024 | Friday | News
Menarini Group and Insilico Medicine ink oncology deal worth $500 M

The Menarini Group, a leading international pharmaceutical and diagnostics company headquartered in Italy, and Stemline ...

January 5, 2024 | Friday | News